Cargando…
The Provocative Roles of Platelets in Liver Disease and Cancer
Both platelets and the liver play important roles in the processes of coagulation and innate immunity. Platelet responses at the site of an injury are rapid; their immediate activation and structural changes minimize the loss of blood. The majority of coagulation proteins are produced by the liver—a...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335590/ https://www.ncbi.nlm.nih.gov/pubmed/34367949 http://dx.doi.org/10.3389/fonc.2021.643815 |
_version_ | 1783733141903507456 |
---|---|
author | Kanikarla Marie, Preeti Fowlkes, Natalie W. Afshar-Kharghan, Vahid Martch, Stephanie L. Sorokin, Alexey Shen, John Paul Morris, Van K. Dasari, Arvind You, Nancy Sood, Anil K. Overman, Michael J. Kopetz, Scott Menter, David George |
author_facet | Kanikarla Marie, Preeti Fowlkes, Natalie W. Afshar-Kharghan, Vahid Martch, Stephanie L. Sorokin, Alexey Shen, John Paul Morris, Van K. Dasari, Arvind You, Nancy Sood, Anil K. Overman, Michael J. Kopetz, Scott Menter, David George |
author_sort | Kanikarla Marie, Preeti |
collection | PubMed |
description | Both platelets and the liver play important roles in the processes of coagulation and innate immunity. Platelet responses at the site of an injury are rapid; their immediate activation and structural changes minimize the loss of blood. The majority of coagulation proteins are produced by the liver—a multifunctional organ that also plays a critical role in many processes: removal of toxins and metabolism of fats, proteins, carbohydrates, and drugs. Chronic inflammation, trauma, or other causes of irreversible damage to the liver can dysregulate these pathways leading to organ and systemic abnormalities. In some cases, platelet-to-lymphocyte ratios can also be a predictor of disease outcome. An example is cirrhosis, which increases the risk of bleeding and prothrombotic events followed by activation of platelets. Along with a triggered coagulation cascade, the platelets increase the risk of pro-thrombotic events and contribute to cancer progression and metastasis. This progression and the resulting tissue destruction is physiologically comparable to a persistent, chronic wound. Various cancers, including colorectal cancer, have been associated with increased thrombocytosis, platelet activation, platelet-storage granule release, and thrombosis; anti-platelet agents can reduce cancer risk and progression. However, in cancer patients with pre-existing liver disease who are undergoing chemotherapy, the risk of thrombotic events becomes challenging to manage due to their inherent risk for bleeding. Chemotherapy, also known to induce damage to the liver, further increases the frequency of thrombotic events. Depending on individual patient risks, these factors acting together can disrupt the fragile balance between pro- and anti-coagulant processes, heightening liver thrombogenesis, and possibly providing a niche for circulating tumor cells to adhere to—thus promoting both liver metastasis and cancer-cell survival following treatment (that is, with minimal residual disease in the liver). |
format | Online Article Text |
id | pubmed-8335590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83355902021-08-05 The Provocative Roles of Platelets in Liver Disease and Cancer Kanikarla Marie, Preeti Fowlkes, Natalie W. Afshar-Kharghan, Vahid Martch, Stephanie L. Sorokin, Alexey Shen, John Paul Morris, Van K. Dasari, Arvind You, Nancy Sood, Anil K. Overman, Michael J. Kopetz, Scott Menter, David George Front Oncol Oncology Both platelets and the liver play important roles in the processes of coagulation and innate immunity. Platelet responses at the site of an injury are rapid; their immediate activation and structural changes minimize the loss of blood. The majority of coagulation proteins are produced by the liver—a multifunctional organ that also plays a critical role in many processes: removal of toxins and metabolism of fats, proteins, carbohydrates, and drugs. Chronic inflammation, trauma, or other causes of irreversible damage to the liver can dysregulate these pathways leading to organ and systemic abnormalities. In some cases, platelet-to-lymphocyte ratios can also be a predictor of disease outcome. An example is cirrhosis, which increases the risk of bleeding and prothrombotic events followed by activation of platelets. Along with a triggered coagulation cascade, the platelets increase the risk of pro-thrombotic events and contribute to cancer progression and metastasis. This progression and the resulting tissue destruction is physiologically comparable to a persistent, chronic wound. Various cancers, including colorectal cancer, have been associated with increased thrombocytosis, platelet activation, platelet-storage granule release, and thrombosis; anti-platelet agents can reduce cancer risk and progression. However, in cancer patients with pre-existing liver disease who are undergoing chemotherapy, the risk of thrombotic events becomes challenging to manage due to their inherent risk for bleeding. Chemotherapy, also known to induce damage to the liver, further increases the frequency of thrombotic events. Depending on individual patient risks, these factors acting together can disrupt the fragile balance between pro- and anti-coagulant processes, heightening liver thrombogenesis, and possibly providing a niche for circulating tumor cells to adhere to—thus promoting both liver metastasis and cancer-cell survival following treatment (that is, with minimal residual disease in the liver). Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8335590/ /pubmed/34367949 http://dx.doi.org/10.3389/fonc.2021.643815 Text en Copyright © 2021 Kanikarla Marie, Fowlkes, Afshar-Kharghan, Martch, Sorokin, Shen, Morris, Dasari, You, Sood, Overman, Kopetz and Menter https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kanikarla Marie, Preeti Fowlkes, Natalie W. Afshar-Kharghan, Vahid Martch, Stephanie L. Sorokin, Alexey Shen, John Paul Morris, Van K. Dasari, Arvind You, Nancy Sood, Anil K. Overman, Michael J. Kopetz, Scott Menter, David George The Provocative Roles of Platelets in Liver Disease and Cancer |
title | The Provocative Roles of Platelets in Liver Disease and Cancer |
title_full | The Provocative Roles of Platelets in Liver Disease and Cancer |
title_fullStr | The Provocative Roles of Platelets in Liver Disease and Cancer |
title_full_unstemmed | The Provocative Roles of Platelets in Liver Disease and Cancer |
title_short | The Provocative Roles of Platelets in Liver Disease and Cancer |
title_sort | provocative roles of platelets in liver disease and cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335590/ https://www.ncbi.nlm.nih.gov/pubmed/34367949 http://dx.doi.org/10.3389/fonc.2021.643815 |
work_keys_str_mv | AT kanikarlamariepreeti theprovocativerolesofplateletsinliverdiseaseandcancer AT fowlkesnataliew theprovocativerolesofplateletsinliverdiseaseandcancer AT afsharkharghanvahid theprovocativerolesofplateletsinliverdiseaseandcancer AT martchstephaniel theprovocativerolesofplateletsinliverdiseaseandcancer AT sorokinalexey theprovocativerolesofplateletsinliverdiseaseandcancer AT shenjohnpaul theprovocativerolesofplateletsinliverdiseaseandcancer AT morrisvank theprovocativerolesofplateletsinliverdiseaseandcancer AT dasariarvind theprovocativerolesofplateletsinliverdiseaseandcancer AT younancy theprovocativerolesofplateletsinliverdiseaseandcancer AT soodanilk theprovocativerolesofplateletsinliverdiseaseandcancer AT overmanmichaelj theprovocativerolesofplateletsinliverdiseaseandcancer AT kopetzscott theprovocativerolesofplateletsinliverdiseaseandcancer AT menterdavidgeorge theprovocativerolesofplateletsinliverdiseaseandcancer AT kanikarlamariepreeti provocativerolesofplateletsinliverdiseaseandcancer AT fowlkesnataliew provocativerolesofplateletsinliverdiseaseandcancer AT afsharkharghanvahid provocativerolesofplateletsinliverdiseaseandcancer AT martchstephaniel provocativerolesofplateletsinliverdiseaseandcancer AT sorokinalexey provocativerolesofplateletsinliverdiseaseandcancer AT shenjohnpaul provocativerolesofplateletsinliverdiseaseandcancer AT morrisvank provocativerolesofplateletsinliverdiseaseandcancer AT dasariarvind provocativerolesofplateletsinliverdiseaseandcancer AT younancy provocativerolesofplateletsinliverdiseaseandcancer AT soodanilk provocativerolesofplateletsinliverdiseaseandcancer AT overmanmichaelj provocativerolesofplateletsinliverdiseaseandcancer AT kopetzscott provocativerolesofplateletsinliverdiseaseandcancer AT menterdavidgeorge provocativerolesofplateletsinliverdiseaseandcancer |